Literature DB >> 35507153

Generation of Human iPSC from Small Volume Peripheral Blood Samples.

Doreen Kloos1,2,3, Nico Lachmann4,5,6,7.   

Abstract

The generation of induced pluripotent stem cells (iPSCs) from patients has opened new doors to gain insights into disease pathophysiology and treatment. In particular, the generation of iPSCs from patients who suffer from inherited diseases is of great interest, as most of these diseases are rare and not well studied. As most affected patients are diagnosed during infancy, the derivation of somatic cells for the generation of iPSCs is very much limited. Here we describe a protocol for the generation of human iPSCs from non-mobilized peripheral blood. This protocol can be adapted to all volumes of blood, starting from 1 ml of peripheral blood. Isolated and processed cells can be used for the generation of iPSCs by both, lentiviral and Sendai virus mediated reprogramming, allowing for the rapid generation of patient-specific iPSCs.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Lentivirus; Peripheral blood; Reprogramming; iPSC

Mesh:

Year:  2022        PMID: 35507153     DOI: 10.1007/978-1-0716-1979-7_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  A review of the methods for human iPSC derivation.

Authors:  Nasir Malik; Mahendra S Rao
Journal:  Methods Mol Biol       Date:  2013

2.  Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.

Authors:  Kathrin Haake; Tim Wüstefeld; Sylvia Merkert; Doreen Lüttge; Gudrun Göhring; Bernd Auber; Ulrich Baumann; Nico Lachmann
Journal:  Stem Cell Res       Date:  2020-01-17       Impact factor: 2.020

3.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

4.  Generation of three induced pluripotent stem cell lines (MHHi012-A, MHHi013-A, MHHi014-A) from a family with Loeys-Dietz syndrome carrying a heterozygous p.M253I (c.759G>A) mutation in the TGFBR1 gene.

Authors:  Praeploy Pongpamorn; Julia Dahlmann; Alexandra Haase; Carolin Theresa Ebeling; Sylvia Merkert; Gudrun Göhring; Nico Lachmann; Andreas Martens; Axel Haverich; Ulrich Martin; Ruth Olmer
Journal:  Stem Cell Res       Date:  2020-02-04       Impact factor: 2.020

5.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

Review 6.  Drug screening for human genetic diseases using iPSC models.

Authors:  Matthew S Elitt; Lilianne Barbar; Paul J Tesar
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

7.  Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation.

Authors:  Sylvia Merkert; Madline Schubert; Alexandra Haase; Hettie M Janssens; Bob Scholte; Nico Lachmann; Gudrun Göhring; Ulrich Martin
Journal:  Stem Cell Res       Date:  2020-03-25       Impact factor: 2.020

8.  Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis.

Authors:  Nico Lachmann; Christine Happle; Mania Ackermann; Doreen Lüttge; Martin Wetzke; Sylvia Merkert; Miriam Hetzel; George Kensah; Monica Jara-Avaca; Adele Mucci; Jelena Skuljec; Anna-Maria Dittrich; Nils Pfaff; Sebastian Brennig; Axel Schambach; Doris Steinemann; Gudrun Göhring; Tobias Cantz; Ulrich Martin; Nicolaus Schwerk; Gesine Hansen; Thomas Moritz
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

9.  Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy.

Authors:  Akram Al Abbar; Siew Ching Ngai; Nadine Nograles; Suleiman Yusuf Alhaji; Syahril Abdullah
Journal:  Biores Open Access       Date:  2020-04-28

Review 10.  Adenosine deaminase deficiency: a review.

Authors:  Aisling M Flinn; Andrew R Gennery
Journal:  Orphanet J Rare Dis       Date:  2018-04-24       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.